Related Experiment Video

Updated: Aug 10, 2026

Perspectives on Neuroscience
26:41

Perspectives on Neuroscience

Published on: July 31, 2007

Neurocognitive outcomes: the year in review

John M Murkin1

  • 1University of Western Ontario, London, Ontario, Canada. jmurkin@uwo.ca

Insights

Postoperative cognitive dysfunction after cardiac surgery may be influenced by factors beyond cerebral emboli, such as anemia and hypoxia. Further research into perioperative care is essential for understanding and mitigating these risks.

Area of Science:

  • Neurology
  • Cardiology
  • Critical Care Medicine

Background:

  • Cardiac surgery can lead to postoperative neurological and cognitive dysfunction.
  • The exact causes and incidence of this dysfunction are still under investigation.
  • Understanding these factors is crucial for improving patient outcomes.

Purpose of the Study:

  • To review recent literature on the causes and incidence of postoperative neurological and cognitive dysfunction after cardiac surgery.
  • To evaluate the role of cerebral emboli and other perioperative factors.
  • To identify areas for future research.

Main Methods:

  • Literature review of recent studies on cardiac surgery and cognitive dysfunction.
  • Analysis of studies using transcranial Doppler for cerebral emboli detection.
  • Examination of research on perioperative factors like anemia, hypoxia, and pre-existing conditions.

Main Results:

  • While beating-heart surgery may reduce cerebral emboli, cognitive dysfunction rates can be similar to conventional cardiopulmonary bypass.
  • Perioperative anemia and hypoxia are identified as significant factors potentially impacting cognitive function.
  • Pre-existing neurological impairment complicates the assessment of surgical impact.

Conclusions:

  • Cerebral embolization is a concern, but other perioperative factors like anemia and hypoxia may be equally or more important for cognitive dysfunction.
  • Further investigation into perioperative care, including blood glucose and temperature management, is warranted.
  • The findings highlight the complexity of preventing neurological deficits after cardiac procedures.
Abstract

Related Concept Videos

Neuroplasticity01:01

Neuroplasticity

Neuroplasticity reflects the brain's remarkable capacity to adapt and evolve, responding dynamically to learning, experiences, or injury by reorganizing its neural circuitry. This reorganization involves creating new neural connections and refining old ones through a series of biological processes that contribute to the brain's lifelong development and adaptability.
Role of Neurotransmitters in Memory01:23

Role of Neurotransmitters in Memory

Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
 Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is critical for...
Cognitivism01:17

Cognitivism

Cognitive psychology emerged as a significant field in the mid-20th century. It focused on understanding humans' internal mental processes. This approach emphasizes how people perceive, remember, think, and solve problems—elements critical to human cognition.
Previously dominated by behaviorism, which prioritized observable behaviors and largely ignored mental processes, psychology transformed in the 1950s. Cognitive psychologists argue that understanding how we think and process information is...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Long-term Depression01:03

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over time, all...